Dominik Höchli has served as an independent director of Abivax since April 2025. He has over two decades of leadership experience in global biopharma, most notably a 20-year tenure at AbbVie/Abbott, where he was Vice President of Global Marketing for Immunology and later Head of Global Medical Affairs. He served as Interim Chief Executive Officer of Catapult Therapeutics from 2021 to 2024, founded the pharmaceutical strategy consultancy Abinode, and serves on the board of Molecular Partners AG, where he sits on the Audit Committee and the Research & Development Committee. He received his medical degree (M.D.) from the University of Bern, Switzerland. He is a member of the Science and Clinical Committee and the Commercial Committee.